Journal of Dental Anesthesia and Pain Medicine

  • 제24권1호
  • /
  • Pages.47-56
  • /
  • 2024
  • /
  • 2383-9309(pISSN)
  • /
  • 2383-9317(eISSN)
대한치과마취과학회 (The Korean Dental Society of Anesthsiology)
권호 표지
DOI QR코드

DOI QR Code

The effect of perineural injection therapy on neuropathic pain: a retrospective study

  • Haekyu Kim (Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University) ;
  • Hyae Jin Kim (Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University) ;
  • Young-Hoon Jung (Department of Anesthesia and Pain Medicine, Biomedical research institute, Pusan National University Hospital) ;
  • Wangseok Do (Department of Anesthesia and Pain Medicine, Biomedical research institute, Pusan National University Hospital) ;
  • Eun-Jung Kim (Department of Dental Anesthesia and Pain Medicine, School of Dentistry, Pusan National University, Dental Research Institute)
  • 투고 : 2024.01.04
  • 심사 : 2024.01.24
  • 발행 : 2024.02.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Among the various pain-related diseases that can be encountered at the clinic, there is a neuropathic pain that is difficult to treat. Numerous methods have been proposed to treat neuropathic pain, such as taking medication, nerve block with lidocaine, or neurolysis with alcohol or phenol. Recently, a method of perineural injection using dextrose instead of lidocaine was proposed. This study was designed to compare the effects of perineural injection therapy (PIT) with buffered 5% dextrose or 0.5% lidocaine on neuropathic pain. Methods: The data were collected from the database of pain clinic from August 1st, 2019 to December 31st, 2022 without any personal information. The inclusion criteria were patients diagnosed with postherpetic neuralgia (PHN), trigeminal neuralgia (TN), complex regional pain syndrome (CRPS), or peripheral neuropathy (PN), and patients who had undergone PIT with buffered 5% dextrose (Dextrose group) or 0.5% lidocaine (Lidocaine group) for pain control. The data of patients, namely sex, age, and pain score (numerical rating scale, NRS) were collected before PIT. The data of NRS, side effects, and satisfaction grade (excellent, good, fair, or poor) were collected one week after each of the four PIT, and two weeks after the last PIT. Results: Overall, 112 subjects were enrolled. The Dextrose group included 89 and Lidocaine group included 23 patients. Because the number of patients in the Lidocaine group was too small to allow statistical analysis, the trend in Lidocaine group was just observed in each disease. There were no significant side effects except for a few bruise cases on the site of injection in all groups. The NRS in most Dextrose groups except CRPS were reduced significantly; however, the Lidocaine group showed a trend of pain reduction only in PHN. The Dextrose group except CRPS showed increased satisfaction two weeks after the final PIT. Conclusion: From the results, it is suggested that PIT with buffered 5% dextrose may have a good effect for neuropathic pain without any side effect except for patients with CRPS. This may offer a window into a new tool that practitioners can employ in their quest to help patients with neuropathic pain.

키워드

과제정보

The study was funded by the Basic Research Support Project of Pusan National University.

참고문헌

  1. Smith PA. Neuropathic pain; what we know and what we should do about it. Front Pain Res (Lausanne) 2023; 4: 1220034.
  2. Park HJ, Moon DE. Pharmacologic management of chronic pain. Korean J Pain 2010; 23: 99-108. https://doi.org/10.3344/kjp.2010.23.2.99
  3. Riediger C, Schuster T, Barlinn K, Maier S, Weitz J, Siepmann T. Adverse effects of antidepressants for chronic pain: a systematic review and meta-analysis. Front Neurol 2017; 8: 307.
  4. Waldman SD. Pain Management. 2nd ed. Saunders Elsevier. 2011.
  5. Geppetti P, Holzer P. Neurogenic Inflammation: Taylor & Francis; 1996.
  6. Lyftogt J. Subcutaneous prolotherapy for achilles tendinopathy: the best solution?. Australasian Musculoskeletal Medicine 2007; 12: 107-9.
  7. Hashimoto K, Sakura S, Bollen AW, Ciriales R, Drasner K. Comparative toxicity of glucose and lidocaine administered intrathecally in the rat. Reg Anesth Pain Med 1998; 23: 444-50. https://doi.org/10.1097/00115550-199823050-00003
  8. Sakura S, Chan VW, Ciriales R, Drasner K. The addition of 7.5% glucose does not alter the neurotoxicity of 5% lidocaine administered intrathecally in the rat. Anesthesiology 1995; 82: 236-40. https://doi.org/10.1097/00000542-199501000-00028
  9. Tsui BCH, Kropelin B. The electrophysiological effect of dextrose 5% in water on single-shot peripheral nerve stimulation. Anesth Analg 2005; 100: 1837-9. https://doi.org/10.1213/01.ANE.0000153020.84780.A5
  10. Dufour E, Donat N, Jaziri S, Kurdi O, Couturier C, Dreyfus JF, et al. Ultrasound-guided perineural circumferential median nerve block with and without prior dextrose 5% hydrodissection: a prospective randomized double-blinded noninferiority trial. Anesth Analg 2012; 115: 728-33. https://doi.org/10.1213/ANE.0b013e31825fa37d
  11. Yoshii Y, Zhao C, Schmelzer JD, Low PA, An KN, Amadio PC. The effects of hypertonic dextrose injection on connective tissue and nerve conduction through the rabbit carpal tunnel. Arch Phys Med Rehabil 2009; 90: 333-9. https://doi.org/10.1016/j.apmr.2008.07.028
  12. Yoshii Y, Zhao C, Schmelzer JD, Low PA, An KN, Amadio PC. Effects of hypertonic dextrose injections in the rabbit carpal tunnel. J Orthop Res 2011; 29: 1022-7. https://doi.org/10.1002/jor.21297
  13. Kim MY, Na YM, Moon JH. Comparison on treatment effects of dextrose water, saline, and lidocaine for trigger point injection. Ann Rehabil Med 1997; 21: 967-73.
  14. Weglein AD. Neural Prolotherapy. Journal of Prolotherapy 2011; 3: 639-43.
  15. Conaway E, Browning B. Neural prolotherapy for neuralgia. Journal of Prolotherapy 2014; 6: e928-e31.
  16. Wu YT, Ho TY, Chou YC, Ke MJ, Li TY, Tsai CK, et al. Six-month efficacy of perineural dextrose for carpal tunnel syndrome: a prospective, randomized, double-blind, controlled trial. Mayo Clin Proc 2017; 92: 1179-89. https://doi.org/10.1016/j.mayocp.2017.05.025
  17. Yelland MJ, Sweeting KR, Lyftogt JA, Ng SK, Scuffham PA, Evans KA. Prolotherapy injections and eccentric loading exercises for painful achilles tendinosis: a randomised trial. Br J Sports Med 2011; 45: 421-8. https://doi.org/10.1136/bjsm.2009.057968
  18. Rabago D, Patterson JJ, Mundt M, Kijowski R, Grettie J, Segal NA, et al. Dextrose prolotherapy for knee osteoarthritis: a randomized controlled trial. Ann Fam Med 2013; 11: 229-37. https://doi.org/10.1370/afm.1504
  19. Bertrand H, Kyriazis M, Reeves KD, Lyftogt J, Rabago D. Topical mannitol reduces capsaicin-induced pain: results of a pilot-level, double-blind, randomized controlled trial. PM R 2015; 7: 1111-7. https://doi.org/10.1016/j.pmrj.2015.05.002
  20. Murakawa Y, Zhang W, Pierson CR, Brismar T, Ostenson CG, Efendic S, et al. Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy. Diabetes Metab Res Rev 2002; 18: 473-83. https://doi.org/10.1002/dmrr.326
  21. Zamami Y, Takatori S, Yamawaki K, Miyashita S, Mio M, Kitamura Y, et al. Acute hyperglycemia and hyperinsulinemia enhance adrenergic vasoconstriction and decrease calcitonin gene-related peptide-containing nerve-mediated vasodilation in pithed rats. Hypertens Res 2008; 31: 1033-44. https://doi.org/10.1291/hypres.31.1033
  22. Wei Z, Wang L, Han J, Song J, Yao L, Shao L, et al. Decreased expression of transient receptor potential vanilloid 1 impaires the postischemic recovery of diabetic mouse hearts. Circ J 2009; 73: 1127-32. https://doi.org/10.1253/circj.CJ-08-0945
  23. Willis WD Jr. The role of TRPV1 receptors in pain evoked by noxious thermal and chemical stimuli. Exp Brain Res 2009; 196: 5-11. https://doi.org/10.1007/s00221-009-1760-2
  24. Brito R, Sheth S, Mukherjea D, Rybak LP, Ramkumar V. TRPV1: a potential drug target for treating various diseases. Cells 2014; 3: 517-45. https://doi.org/10.3390/cells3020517
  25. Fernandes ES, Fernandes MA, Keeble JE. The functions of TRPA1 and TRPV1: moving away from sensory nerves. Br J Pharmacol 2012; 166: 510-21. https://doi.org/10.1111/j.1476-5381.2012.01851.x
  26. Lyftogt J. Subcutaneous prolotherapy treatment of refractory knee, shoulder, and lateral elbow pain. Australasian Musculoskeletal Medicine 2007; 12: 110-2.
  27. Pybus P, Rheumatoid Disease Foundation, (U. S.). Intraneural injections for rheumatoid arthritis and osteoarthritis: and reprint for physicians and layman, the control of pain in arthritis of the knee. Rheumatoid Disease Foundation. 1988.
  28. Hilton J. The classic: on rest and pain: lecture XIV. Clin Orthop Relat Res 2009; 467: 2208-14. https://doi.org/10.1007/s11999-009-0928-1
  29. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988; 33: 87-107. https://doi.org/10.1016/0304-3959(88)90209-6
  30. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997; 389: 816-24. https://doi.org/10.1038/39807
  31. Palazzo E, Luongo L, de Novellis V, Rossi F, Marabese I, Maione S. Transient receptor potential vanilloid type 1 and pain development. Curr Opin Pharmacol 2012; 12: 9-17. https://doi.org/10.1016/j.coph.2011.10.022
  32. Bove GM, Light AR. Calcitonin gene-related peptide and peripherin immunoreactivity in nerve sheaths. Somatosens Mot Res 1995; 12: 49-57. https://doi.org/10.3109/08990229509063141
  33. Maniquis-Smigel L, Reeves KD, Rosen HJ, Lyftogt J, Graham-Coleman C, Cheng AL, et al. Analgesic effect and potential cumulative benefit from caudal epidural d5w in consecutive participants with chronic low-back and buttock/leg pain. J Altern Complement Med 2018; 24: 1189-96. https://doi.org/10.1089/acm.2018.0085
  34. Birklein F, Schmelz M. Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS). Neurosci Lett 2008; 437: 199-202. https://doi.org/10.1016/j.neulet.2008.03.081
  35. Thor JA, Mohamed Hanapi NH, Halil H, Suhaimi A. Perineural injection therapy in the management of complex regional pain syndrome: a sweet solution to pain. Pain Med 2017; 18: 2041-5. https://doi.org/10.1093/pm/pnx063
  36. Buntragulpoontawee M, Chang KV, Vitoonpong T, Pornjaksawan S, Kitisak K, Saokaew S, et al. The effectiveness and safety of commonly used injectates for ultrasound-guided hydrodissection treatment of peripheral nerve entrapment syndromes: a systematic review. Front Pharmacol 2021; 11: 621150.
  37. Wu YT, Wu CH, Lin JA, Su DC, Hung CY, Lam SKH. Efficacy of 5% dextrose water injection for peripheral entrapment neuropathy: a narrative review. Int J Mol Sci 2021; 22: 12358.
  38. Chen LC, Ho TY, Shen YP, Su YC, Li TY, Tsai CK, et al. Perineural dextrose and corticosteroid injections for ulnar neuropathy at the elbow: a randomized double-blind trial. Arch Phys Med Rehabil 2020; 101: 1296-303.  https://doi.org/10.1016/j.apmr.2020.03.016